Thus, experimental and clinical studies concur in the conclusion that, although leptin may possess an insulin-independent glucose-lowering effect, this effect has already become manifest in patients with insulin-treated type 1 diabetes, and additional beneficial effects on blood glucose levels of leptin treatment are therefore not to be expected. The gene discussed is LEP; the disease is type 1 diabetes mellitus.